| ISPC 0.1365 17.17% | CTNT 0.0953 -40.73% | BYND 0.8226 5.19% | YXT 0.496 34.05% | TZA 5.08 -6.45% | EFOI 6.49 210.53% | TSLL 13.9 6.35% | NVDA 201.68 1.68% | BITO 10.63 2.71% | NFLX 97.31 -9.72% | INTC 68.5 0.00% | ZSPC 0.0536 -38.46% | TQQQ 58.59 3.83% | SOXS 18.87 -6.95% | TSLA 400.62 3.01% | XLE 55.02 -2.76% | AMC 1.86 15.53% | SCO 8.47 9.72% | PLUG 2.78 -2.80% | BMNG 1.6 4.58% | IBIT 43.94 2.83% | AAL 12.78 4.16% | BZAI 2.52 45.66% | CRML 12.56 35.49% | SOFI 19.43 2.10% | HIVE 2.51 14.87% | GRAB 4.21 4.73% | SPY 710.14 1.21% | SQQQ 56.39 -3.79% | SOXL 94.68 7.14% | SMR 12.65 10.87% | BMNR 22.95 2.27% | SNAP 6.03 0.17% | UCAR 1.49 29.57% | HIMS 28.82 6.78% | LZMH 0.1736 -84.07% | HYG 80.65 0.37% | DRIP 5.25 9.83% | ONDS 10 -1.96% | DVLT 0.758 -9.49% | AAPL 270.23 2.59% | QQQ 648.85 1.31% | MARA 11.6 0.43% | MSTR 166.52 11.80% | AMZN 250.56 0.34% | PLTR 146.39 2.54% | SPDN 9.13 -1.19% | PBM 7.6 29.47% | IONQ 46.09 3.16% | MSFT 422.79 0.60%

CNO Financial Group, Inc. (NYSE:CNO) Insider Sale and Financial Overview

CNO Financial Group, Inc. (NYSE:CNO) is a prominent player in the insurance industry, providing health and life insurance products. The company operates through its subsidiaries, including Bankers Life and Casualty Company, Colonial Penn Life Insurance Company, and Washington National Insurance Company. CNO competes with other insurance giants like MetLife and Prudential Financial. On February 12, 2026, Matthew J. Zimpfer, CNO's General Counsel, sold 30,970 shares of the company's common stock at approximately $42.93 each. This transaction leaves Zimpfer with 307,937 shares.

Despite this sale, CNO continues to reward its shareholders with a quarterly cash dividend of $0.17 per share, payable on March 24, 2026, to those recorded by March 10, 2026. CNO's financial metrics provide insight into its market position. The company's price-to-earnings (P/E) ratio is around 32.45, indicating investor confidence in its earnings potential. The price-to-sales ratio of 0.92 suggests that the market values CNO's sales at less than one times its revenue, while the enterprise value to sales ratio of 1.60 reflects its total valuation compared to sales. The enterprise value to operating cash flow ratio stands at approximately 10.71, showing how CNO's valuation compares to its cash flow from operations. The earnings yield is about 3.08%, offering a glimpse into the return on investment for shareholders.

Additionally, the debt-to-equity ratio of 1.54 highlights CNO's reliance on debt financing relative to its equity. CNO's annual meeting of shareholders is scheduled for May 12, 2026, and will be held virtually. Shareholders recorded by March 16, 2026, can participate, vote, and submit questions. Notably, Nina Henderson, a long-serving Board member, will retire at the end of her term, concluding with the annual meeting. Henderson has been instrumental as Chair of the Human Resources and Compensation Committee.

Published on: February 13, 2026